Notice Information
Notice Title
NHS National Generic Pharmaceuticals Wave 14b
Notice Description
NHS National Generic Pharmaceuticals Wave 14b<br/>Offer reference number: CM/PHG/22/5668<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8months)<br/>Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24months)<br/>Housekeeping Products (Hospital Only):<br/>DLN & DNW regions 01/10/2023 -31/01/2025 (16 months)<br/>DLS & DNE regions 01/10/2023 -31/05/2024 (8 months)
Lot Information
Lot 1 - CM/PHG/22/5668/01 - Orals (plus non-parenteral) Products
NHS National Generic Pharmaceuticals Wave 14b
Offer reference number: CM/PHG/22/5668
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Lot 2 - CM/PHG/22/5668/02 - Hospital Only Products (DCE and DSW regions)NHS National Generic Pharmaceuticals Wave 14b
Offer reference number: CM/PHG/22/5668
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Lot 3 - CM/PHG/22/5668/03 Housekeeping Products (Hospital only)NHS National Generic Pharmaceuticals Wave 14b
Offer reference number: CM/PHG/22/5668
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Housekeeping Products (Hospital Only):
DLN & DNW regions 01/10/2023 - 31/01/2025 (16 months)
DLS & DNE regions 01/10/2023 - 31/05/2024 (8 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Options: Option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03b259
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/023443-2023
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £566,421,816 £100M-£1B
- Lots Value
- £566,421,816 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 10 Aug 20233 years ago
- Submission Deadline
- 18 Apr 2023Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS England
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Postcode Area
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Supplier Information
- Number of Suppliers
- 104
- Supplier Names
Dr.Reddy's Laboratories (UK) Limited
Glenmark Pharmaceuticals Europe Ltd
Mercury Pharmaceuticals Limited
Norgine Pharmaceuticals Limited
Stirling Anglian Pharmaceuticals Ltd
Otsuka Pharmaceuticals UK Limited
MSN Laboratories Europe Limited
Novartis Pharmaceuticals UK Ltd
Further Information
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.